Skip to main content
. 2021 Jan 13;15(7):1120–1129. doi: 10.1093/ecco-jcc/jjab012

Figure 2.

Figure 2.

Patient disposition.

*In 2019, the sponsor made the decision to close the phase 2 TOUCHSTONE study after all active patients had completed at least 4 years [200 weeks] of follow-up.